Market Overview

Trade RXN stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
6/22/18OppenheimerMaintainsOutperformOutperform35.0
2/15/18BarclaysInitiates Coverage OnEqual-Weight30.0
2/08/18OppenheimerUpgradesPerformOutperform
Show more Loading articles...

Earnings View Earnings

Q4 2018 EST Actual Surprise
EPS: 0.39 0.42 0.03
Rev: 551.94M 575.20M 23.26M
Q1 2019 EST Actual Surprise
EPS: Expected
2018-07-30
Rev:

Company Profile